[SCHEDULE 13G/A] SeaStar Medical Holding Corporation SEC Filing
Armistice Capital, LLC and Steven Boyd filed an amended Schedule 13G reporting collective beneficial ownership of 1,466,096 shares of SeaStar Medical Holding Corp common stock, equal to 4.99% of the class. The filing states Armistice Capital is the investment manager of Armistice Capital Master Fund Ltd., the direct holder, and that Armistice exercises voting and investment power over the Master Fund's holdings; Mr. Boyd, as managing member, is similarly reported. The submission characterizes the position as held in the ordinary course of business and not for the purpose of changing or influencing control.
Armistice Capital, LLC e Steven Boyd hanno presentato un emendamento al Schedule 13G dichiarando la detenzione collettiva di 1.466.096 azioni ordinarie di SeaStar Medical Holding Corp, pari al 4,99% della classe. Il documento precisa che Armistice Capital 猫 il gestore degli investimenti di Armistice Capital Master Fund Ltd., il detentore diretto, e che Armistice esercita il potere di voto e di investimento sulle partecipazioni del Master Fund; lo stesso ruolo 猫 attribuito a Mr. Boyd in qualit脿 di membro gestionale. La comunicazione definisce la posizione come detenuta nel normale corso dell'attivit脿 e non con l'intento di modificare o influenzare il controllo.
Armistice Capital, LLC y Steven Boyd presentaron un Schedule 13G enmendado informando la propiedad beneficiosa colectiva de 1.466.096 acciones ordinarias de SeaStar Medical Holding Corp, equivalentes al 4,99% de la clase. La presentaci贸n indica que Armistice Capital es el gestor de inversiones de Armistice Capital Master Fund Ltd., el titular directo, y que Armistice ejerce el poder de voto y de inversi贸n sobre las participaciones del Master Fund; al se帽or Boyd, como miembro gerente, se le atribuye una posici贸n similar. La declaraci贸n califica la posici贸n como mantenida en el curso normal del negocio y no con el prop贸sito de cambiar o influir en el control.
Armistice Capital, LLC鞕� 鞀ろ嫲敫� 氤挫澊霌滊姅 靾橃爼霅� Schedule 13G毳� 鞝滌稖頃橃棳 SeaStar Medical Holding Corp 氤错喌欤� 1,466,096欤�毳� 歆戫暕鞝侅溂搿� 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頄堨溂氅�, 鞚措姅 頃措嫻 韥措灅鞀れ潣 4.99%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滌棎電� Armistice Capital鞚� 歆侅爲 氤挫湢鞛愳澑 Armistice Capital Master Fund Ltd.鞚� 韴瀽 毵る媹鞝�鞚措┌, Armistice臧� 毵堨姢韯� 韼�霌� 氤挫湢攵勳棎 雽�頃� 鞚橁舶甓� 氚� 韴瀽甓岇潉 頄夓偓頃滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氤挫澊霌滊姅 毵る媹歆� 氅る矂搿滌劀 鞙犾偓頃� 甓岉暅鞚� 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅橃棃鞀惦媹雼�. 頃措嫻 韽靺橃潃 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅� 瓴�鞚措┌ 歆�氚瓣秾 氤�瓴届澊雮� 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞚� 鞎勲嫎鞚� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟.
Armistice Capital, LLC et Steven Boyd ont d茅pos茅 un Schedule 13G modifi茅 signalant une d茅tention b茅n茅ficiaire collective de 1 466 096 actions ordinaires de SeaStar Medical Holding Corp, repr茅sentant 4,99 % de la cat茅gorie. Le d茅p么t indique qu'Armistice Capital est le gestionnaire d'investissement d'Armistice Capital Master Fund Ltd., le d茅tenteur direct, et qu'Armistice exerce le pouvoir de vote et d'investissement sur les avoirs du Master Fund ; M. Boyd, en tant que membre dirigeant, est d茅clar茅 de mani猫re similaire. La soumission qualifie la position de d茅tenue dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le.
Armistice Capital, LLC und Steven Boyd reichten eine berichtigte Schedule 13G ein und meldeten gemeinschaftliches wirtschaftliches Eigentum an 1.466.096 Aktien der Stammaktien von SeaStar Medical Holding Corp, was 4,99 % der Klasse entspricht. Die Einreichung besagt, dass Armistice Capital Investment Manager des direkt haltenden Armistice Capital Master Fund Ltd. ist und dass Armistice das Stimm- und Investitionsrecht 眉ber die Best盲nde des Master Funds aus眉bt; Herrn Boyd wird als gesch盲ftsf眉hrendem Mitglied eine analoge Stellung zugeschrieben. In der Meldung wird die Position als im ordentlichen Gesch盲ftsverlauf gehalten und nicht mit der Absicht, die Kontrolle zu 盲ndern oder zu beeinflussen, bezeichnet.
- Transparent disclosure of beneficial ownership and voting power by Armistice Capital and Steven Boyd
- Position reported as passive and held in the ordinary course, indicating no declared intent to influence control
- None.
Insights
TL;DR: Armistice reports a 4.99% passive stake in SeaStar Medical, disclosed under Schedule 13G as ordinary-course ownership.
The filing documents a sub-5% position, which is typically treated as non-activist and passive under SEC rules. The ownership is held through an investment fund with Armistice providing voting and investment power, meaning market participants should view this as manager-directed exposure rather than direct corporate control. There are no financing, strategic transactions, or increased ownership triggers reported that would materially change the company鈥檚 governance or capital structure.
TL;DR: This is a standard Schedule 13G/A disclosure showing manager-declared voting power for compliance and transparency; not a control event.
The statement emphasizes that the position is held in the ordinary course and not intended to influence control, fitting Schedule 13G filing criteria. The Master Fund disclaims direct beneficial ownership due to the investment management agreement, while Armistice and Mr. Boyd report shared voting and dispositive power. For governance implications, a sub-5% passive stake generally does not trigger board engagement obligations or change oversight dynamics absent further accumulation or activism.
Armistice Capital, LLC e Steven Boyd hanno presentato un emendamento al Schedule 13G dichiarando la detenzione collettiva di 1.466.096 azioni ordinarie di SeaStar Medical Holding Corp, pari al 4,99% della classe. Il documento precisa che Armistice Capital 猫 il gestore degli investimenti di Armistice Capital Master Fund Ltd., il detentore diretto, e che Armistice esercita il potere di voto e di investimento sulle partecipazioni del Master Fund; lo stesso ruolo 猫 attribuito a Mr. Boyd in qualit脿 di membro gestionale. La comunicazione definisce la posizione come detenuta nel normale corso dell'attivit脿 e non con l'intento di modificare o influenzare il controllo.
Armistice Capital, LLC y Steven Boyd presentaron un Schedule 13G enmendado informando la propiedad beneficiosa colectiva de 1.466.096 acciones ordinarias de SeaStar Medical Holding Corp, equivalentes al 4,99% de la clase. La presentaci贸n indica que Armistice Capital es el gestor de inversiones de Armistice Capital Master Fund Ltd., el titular directo, y que Armistice ejerce el poder de voto y de inversi贸n sobre las participaciones del Master Fund; al se帽or Boyd, como miembro gerente, se le atribuye una posici贸n similar. La declaraci贸n califica la posici贸n como mantenida en el curso normal del negocio y no con el prop贸sito de cambiar o influir en el control.
Armistice Capital, LLC鞕� 鞀ろ嫲敫� 氤挫澊霌滊姅 靾橃爼霅� Schedule 13G毳� 鞝滌稖頃橃棳 SeaStar Medical Holding Corp 氤错喌欤� 1,466,096欤�毳� 歆戫暕鞝侅溂搿� 氤挫湢頃橁碃 鞛堨潓鞚� 氤搓碃頄堨溂氅�, 鞚措姅 頃措嫻 韥措灅鞀れ潣 4.99%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滌棎電� Armistice Capital鞚� 歆侅爲 氤挫湢鞛愳澑 Armistice Capital Master Fund Ltd.鞚� 韴瀽 毵る媹鞝�鞚措┌, Armistice臧� 毵堨姢韯� 韼�霌� 氤挫湢攵勳棎 雽�頃� 鞚橁舶甓� 氚� 韴瀽甓岇潉 頄夓偓頃滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 氤挫澊霌滊姅 毵る媹歆� 氅る矂搿滌劀 鞙犾偓頃� 甓岉暅鞚� 氤挫湢頃� 瓴冹溂搿� 氤搓碃霅橃棃鞀惦媹雼�. 頃措嫻 韽靺橃潃 韱奠儊鞝侅澑 鞓侅梾 瓿检爼鞐愳劀 氤挫湢霅� 瓴�鞚措┌ 歆�氚瓣秾 氤�瓴届澊雮� 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞚� 鞎勲嫎鞚� 氇呾嫓頃橁碃 鞛堨姷雼堧嫟.
Armistice Capital, LLC et Steven Boyd ont d茅pos茅 un Schedule 13G modifi茅 signalant une d茅tention b茅n茅ficiaire collective de 1 466 096 actions ordinaires de SeaStar Medical Holding Corp, repr茅sentant 4,99 % de la cat茅gorie. Le d茅p么t indique qu'Armistice Capital est le gestionnaire d'investissement d'Armistice Capital Master Fund Ltd., le d茅tenteur direct, et qu'Armistice exerce le pouvoir de vote et d'investissement sur les avoirs du Master Fund ; M. Boyd, en tant que membre dirigeant, est d茅clar茅 de mani猫re similaire. La soumission qualifie la position de d茅tenue dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le.
Armistice Capital, LLC und Steven Boyd reichten eine berichtigte Schedule 13G ein und meldeten gemeinschaftliches wirtschaftliches Eigentum an 1.466.096 Aktien der Stammaktien von SeaStar Medical Holding Corp, was 4,99 % der Klasse entspricht. Die Einreichung besagt, dass Armistice Capital Investment Manager des direkt haltenden Armistice Capital Master Fund Ltd. ist und dass Armistice das Stimm- und Investitionsrecht 眉ber die Best盲nde des Master Funds aus眉bt; Herrn Boyd wird als gesch盲ftsf眉hrendem Mitglied eine analoge Stellung zugeschrieben. In der Meldung wird die Position als im ordentlichen Gesch盲ftsverlauf gehalten und nicht mit der Absicht, die Kontrolle zu 盲ndern oder zu beeinflussen, bezeichnet.
FAQ
What stake in SeaStar Medical (ICU) did Armistice Capital report?
Does the Schedule 13G/A indicate Armistice Capital intends to control SeaStar Medical?
Through what vehicle does Armistice hold the shares?
Who signed the Schedule 13G/A for Armistice Capital?
How many votes does Armistice report for this position?
